Market Value138,903,000
Total Holdings63
File Date2022-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LSF / Laird Superfood, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
BDSX / Biodesix, Inc.
VTYX / Ventyx Biosciences, Inc.
SILK / Silk Road Medical, Inc
IMGN / ImmunoGen, Inc.
ETRN / Equitrans Midstream Corporation
GTHX / G1 Therapeutics, Inc.
PXD / Pioneer Natural Resources Company
KALV / KalVista Pharmaceuticals, Inc.
HROW / Harrow, Inc.
IFRX / InflaRx N.V.
TSVT / 2seventy bio, Inc.
PRTA / Prothena Corporation plc
BHVN / Biohaven Ltd.
ARVN / Arvinas, Inc.
TGTX / TG Therapeutics, Inc.
OVV / Ovintiv Inc.
INBX.V / Inhibrx, Inc.
PFE / Pfizer Inc.
CLR / Continental Resources Inc (OKLA)
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
VNDA / Vanda Pharmaceuticals Inc.
AWH / Aspira Women's Health Inc.
BIIB / Biogen Inc.
AKBA / Akebia Therapeutics, Inc.
TPTX / Turning Point Therapeutics Inc
ARNA / Arena Pharmaceuticals Inc
FHTX / Foghorn Therapeutics Inc.
FOLD / Amicus Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
PTGX / Protagonist Therapeutics, Inc.
DCGO / DocGo Inc.
XNCR / Xencor, Inc.
YTEN / Yield10 Bioscience, Inc.
TXMD / TherapeuticsMD, Inc.
IRTC / iRhythm Technologies, Inc.
CNCE / Concert Pharmaceuticals Inc
ISEE / IVERIC bio Inc
CFRX / ContraFect Corp
NARI / Inari Medical, Inc.
ALBO / Albireo Pharma Inc
ANGN / Angion Biomedica Corp
CCXI / ChemoCentryx Inc
AVEO / AVEO Pharmaceuticals Inc
CYTK / Cytokinetics, Incorporated
ACAD / ACADIA Pharmaceuticals Inc.
AXDX / Accelerate Diagnostics, Inc.
NBIX / Neurocrine Biosciences, Inc.
STOK / Stoke Therapeutics, Inc.
MASI / Masimo Corporation
SIEN / Sientra, Inc.
SLNO / Soleno Therapeutics, Inc.
QDEL / QuidelOrtho Corporation
NKTR / Nektar Therapeutics
ELUT / Elutia Inc.
UTHR / United Therapeutics Corporation
BCRX / BioCryst Pharmaceuticals, Inc.
BMY / Bristol-Myers Squibb Company
PHR / Phreesia, Inc.
ALKS / Alkermes plc
APLS / Apellis Pharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
CGEM / Cullinan Therapeutics, Inc.
BLUE / bluebird bio, Inc.
KPTI / Karyopharm Therapeutics Inc.
PGNY / Progyny, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.